Abstract:Chang Yan, 1 De-Song Shen, 1 Xiao-Bo Chen, 2 Dan-Ke SU, 3 Zhong-Guo Liang, 1 Kai-Hua Chen, 1 Ling Li, 1 Xia Liang, 1 Hai Liao, 3 Xiao-Dong Zhu 1, 4 1 Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China; 2 School of First Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China; 3 Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China; 4 Affiliated Wuming Hospital of Guangxi Medical University, Nanning, Guangxi, 530100, People's Republic of China Correspondence: Xiao-Dong Zhu Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, 71 Hedi Road, Nanning City, Guangxi, 530021, People's Republic of China Tel +86 771 533 1466 Email Hai Liao Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China Tel +86 771 533 4950 Email Purpose: We aimed to construct of a nomogram to predict progression-free survival (PFS) in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) with risk stratification using computed tomography (CT) radiomics features and clinical factors. Patients and Methods: A total of 311 patients diagnosed with LA-NPC (stage III–IVa) at our hospital between 2010 and 2014 were included. The region of interest (ROI) of the primary nasopharyngeal mass was manually outlined. Independent sample t -test and LASSO-logistic regression were used for selecting the most predictive radiomics features of PFS, and to generate a radiomics signature. A nomogram was built with clinical factors and radiomics features, and the risk stratification model was tested accordingly. Results: In total, 20 radiomics features most associated with prognosis were selected. The radiomics nomogram, which integrated the radiomics signature and significant clinical factors, showed excellent performance in predicting PFS, with C-index of 0.873 (95% CI: 0.803∼ 0.943), which was better than that of the clinical nomogram (C-index, 0.729, 95% CI: 0.620∼ 0.838) as well as of the TNM staging system (C-index, 0.689, 95% CI: 0.592– 0.787) in validation cohort. The calibration curves and the decision curve analysis (DCA) plot obtained suggested satisfying accuracy and clinical utility of the model. The risk stratification tool was able to predict differences in prognosis of patients in different risk categories ( p < 0.001). Conclusion: CT-based radiomics features, an in particular, radiomics nomograms, have the potential to become an accurate and reliable tool for assisting with prognosis prediction of LA-NPC. Keywords: computed tomography, locoregionally advanced nasopharyngeal carcinoma, radiomics, nomogram Nasopharyngeal carcinoma (NPC) is one of the most prevalent head and neck malignant tumors in China, with a characteristic geographical distribution: the highest incidence is found in southern China. 1 Due to its intrinsic biological characteristics and anatomical features, early disease symptoms and signs are not obvious, and many patients already present locally advanced stage when they are first diagnosed. 2 Given that intensity-modulated radiotherapy (IMRT) is widely used in recent years, the local control of NPC has improved significantly, but patients with advanced disease still tend to experience local recurrence and distant metastasis. 3 Combination of chemotherapy with radiotherapy can enhance the efficacy of radiotherapy alone in eliminating micrometastases, and improve the prognosis of locoregionally advanced nasopharyngeal carcinoma LA-NPC. 4 Nevertheless, such combination strategy can also increase the radiotherapy and chemotherapy related side effects and add to the economic burden of health care. The TNM staging system (AJCC 8th edition) provide important information to help clinicians improve NPC clinical care and diagnosis. However, patients with similar TNM staging often have different prognosis and experience different course of the disease. The reason for this may be related to intrinsic biological variability and tumor heterogeneity in different patients. Therefore, how to personalize treatment regimens to minimize the toxic side effects of aggressive therapies while obtaining a promising prognosis remains a clinical challenge. A reliable prognostic model can assist clinicians with their predictions of a patient's prognosis and help them make more informed therapeutic decisions. Radiomics has become a popular research topic in -Abstract Truncated-

RE: A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma.

Deep learning for locally advanced nasopharyngeal carcinoma prognostication based on pre- and post-treatment MRI

Integrative Scoring System for Survival Prediction in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Multicenter Study

MRI‐Based Deep‐Learning Model for Distant Metastasis‐Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma

Deep convolution neural network model for automatic risk assessment of patients with non-metastatic nasopharyngeal carcinoma

Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network

Abstract 5430: Deep Learning-Based Prognosis Prediction in T3N1 Nasopharyngeal Carcinoma Patients Treated with Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

Predicting prognosis of nasopharyngeal carcinoma based on deep learning: peritumoral region should be valued

A Deep Learning MRI-based Signature May Provide Risk-Stratification Strategies for Nasopharyngeal Carcinoma

Prediction of 5-year Progression-Free Survival in Advanced Nasopharyngeal Carcinoma with Pretreatment PET/CT using Multi-Modality Deep Learning-based Radiomics

Deep learning for the prediction of residual tumor after radiotherapy and treatment decision-making in patients with nasopharyngeal carcinoma based on magnetic resonance imaging

An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features

MRI-Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma

A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Advanced Nasopharyngeal Carcinoma

Boosting Advanced Nasopharyngeal Carcinoma Stage Prediction Using a Two-Stage Classification Framework Based on Deep Learning

Deep learning for risk prediction in patients with nasopharyngeal carcinoma using multi-parametric MRIs

Deep learning pathological microscopic features in endemic nasopharyngeal cancer: Prognostic value and protentional role for individual induction chemotherapy

Deep Learning for Predicting Distant Metastasis in Patients with Nasopharyngeal Carcinoma Based on Pre-Radiotherapy Magnetic Resonance Imaging

A Prognostic and Predictive Model Based on Deep Learning to Identify Optimal Candidates for Intensity-Modulated Radiotherapy Alone in Patients with Stage II Nasopharyngeal Carcinoma: A Retrospective Multicenter Study